UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen

Journal of thrombosis and haemostasis, 2021-04, Vol.19 (4), p.1029-1037

2021

Link zum Volltext

Verfügbarkeit prüfen

Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Cochrane database of systematic reviews, 2020-05, Vol.5 (5), p.CD012852

2020

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence?

Journal of thrombosis and haemostasis, 2021-05, Vol.19 (5), p.1174-1185

2021

Link zum Volltext

Verfügbarkeit prüfen

Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism

Hypertension (Dallas, Tex. 1979), 2020-03, Vol.75 (3), p.781-787

2020

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular risk prediction models for women in the general population: A systematic review

PloS one, 2019-01, Vol.14 (1), p.e0210329-e0210329

2019

Link zum Volltext

Verfügbarkeit prüfen

Antithrombotic therapy for live birth in women with recurrent pregnancy loss: do not confound available high-level evidence

Human reproduction (Oxford), 2021-12, Vol.37 (1), p.190-191

2021

Link zum Volltext

Verfügbarkeit prüfen

Everything the clinician needs to know about evidence-based anticoagulation in pregnancy

Blood reviews, 2019-01, Vol.33, p.82-97

2019

Link zum Volltext

Verfügbarkeit prüfen

The relationship between DOAC levels and clinical outcomes: The measures tell the tale

Journal of thrombosis and haemostasis, 2020-12, Vol.18 (12), p.3163-3168

2020

Link zum Volltext

Verfügbarkeit prüfen

Concerns about the ALIFE2 trial – Authors’ reply

The Lancet (British edition), 2024-01, Vol.403 (10423), p.248-248

2024

Link zum Volltext

Verfügbarkeit prüfen

Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin

Thrombosis and haemostasis, 2017, Vol.117 (4), p.809

2017

Link zum Volltext

Verfügbarkeit prüfen

Sex matters: Practice 5P's when treating young women with venous thromboembolism

Journal of thrombosis and haemostasis, 2019-09, Vol.17 (9), p.1417-1429

2019

Link zum Volltext

Verfügbarkeit prüfen

The relationship between DOAC levels and clinical outcomes: The measures tell the tale–Response from original authors Lijfering et al

Journal of thrombosis and haemostasis, 2021-04, Vol.19 (4), p.1136-1138

2021

Link zum Volltext

Verfügbarkeit prüfen

Current and future burden of venous thrombosis: Not simply predictable

Research and practice in thrombosis and haemostasis, 2018-04, Vol.2 (2), p.199-208

2018

Link zum Volltext

Verfügbarkeit prüfen

Global impact of World Sepsis Day on digital awareness of sepsis: an evaluation using Google Trends

Critical care (London, England), 2018-03, Vol.22 (1), p.61-61, Article 61

2018

Link zum Volltext

Verfügbarkeit prüfen

Imaging for the exclusion of pulmonary embolism in pregnancy

Cochrane database of systematic reviews, 2017-01, Vol.1 (1), p.CD011053-CD011053

2017

Link zum Volltext

Verfügbarkeit prüfen

Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Cochrane database of systematic reviews, 2017-11, Vol.2017 (11)

2017

Link zum Volltext

Verfügbarkeit prüfen

Implementation of a clinical decision-making tool for perioperative management of vitamin K antagonists in patients with atrial fibrillation

Thrombosis research, 2023-08, Vol.228, p.200-202

2023

Link zum Volltext

Verfügbarkeit prüfen

Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study

Journal of thrombosis and haemostasis, 2021-07, Vol.19 (7), p.1759-1763

2021

Link zum Volltext

Verfügbarkeit prüfen

Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial

The Lancet (British edition), 2023-07, Vol.402 (10395), p.54-61

2023

Link zum Volltext

Verfügbarkeit prüfen

Endogenous sex hormones and risk of venous thromboembolism in young women

Journal of thrombosis and haemostasis, 2019-08, Vol.17 (8), p.1297-1304

2019

Link zum Volltext

Verfügbarkeit prüfen

Progress of the ALIFE2 study: A dynamic road towards more evidence

Thrombosis research, 2020-06, Vol.190, p.39-44

2020

Link zum Volltext

Verfügbarkeit prüfen

Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis: A Case-Control Study

Stroke (1970), 2019-02, Vol.50 (2), p.501-503

2019

Link zum Volltext

Verfügbarkeit prüfen

Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women

Journal of thrombosis and haemostasis, 2024-03

2024

Link zum Volltext

Verfügbarkeit prüfen

Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter?

ERJ open research, 2020-01, Vol.6 (1), p.163

2020

Link zum Volltext

Verfügbarkeit prüfen

Sex‐specific aspects of venous thromboembolism: What is new and what is next?

Research and practice in thrombosis and haemostasis, 2022-05, Vol.6 (4), p.e12722-n/a, Article e12722

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(36)

Publikationsform

Artikel
(42)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Effect of gender‐affirming hormone use on coagulation profiles in transmen and transwomen

Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome—What is the evidence?

Hypertensive Complications of Pregnancy and Risk of Venous Thromboembolism

Cardiovascular risk prediction models for women in the general population: A systematic review

Antithrombotic therapy for live birth in women with recurrent pregnancy loss: do not confound available high-level evidence

Everything the clinician needs to know about evidence-based anticoagulation in pregnancy

The relationship between DOAC levels and clinical outcomes: The measures tell the tale

Concerns about the ALIFE2 trial – Authors’ reply

Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarin

Sex matters: Practice 5P's when treating young women with venous thromboembolism

The relationship between DOAC levels and clinical outcomes: The measures tell the tale–Response from original authors Lijfering et al

Current and future burden of venous thrombosis: Not simply predictable

Global impact of World Sepsis Day on digital awareness of sepsis: an evaluation using Google Trends

Imaging for the exclusion of pulmonary embolism in pregnancy

Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss

Implementation of a clinical decision-making tool for perioperative management of vitamin K antagonists in patients with atrial fibrillation

Sex‐specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants—A substudy of the EINSTEIN‐PE study

Heparin for women with recurrent miscarriage and inherited thrombophilia (ALIFE2): an international open-label, randomised controlled trial

Endogenous sex hormones and risk of venous thromboembolism in young women

Progress of the ALIFE2 study: A dynamic road towards more evidence

Postpartum Period Is a Risk Factor for Cerebral Venous Thrombosis: A Case-Control Study

Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women

Prognostic characteristics and body mass index in patients with pulmonary embolism: does size matter?

Sex‐specific aspects of venous thromboembolism: What is new and what is next?

Suchergebnisse filtern